News & Events

   • World-first phase 3 study of a microbiome protector    • Da Volterra becomes a pioneering late-stage clinical company…

Since its inception in 2009, Biotech Showcase has grown into one of the biopharma industry’s leading investor conferences, and is…

Da Volterra is presenting new data at the European Society for Medical Oncology (ESMO) Immuno-Oncology 2020 Virtual Meeting this week…

Confirmation of the negative impact of antibiotics on immuno-oncology patients’ survival Da Volterra is presenting new data at the Society…

The Galien Medstartup Partnering Week is a 5 days event dedicated to exhilirating online discussions and debates focused on global…

BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. We look forward to virtually meeting with investors and…

The e-poster highlights the need to develop innovative approaches to protect the intestinal microbiota of cancer patients treated with immune…

   • First clinical study evaluating the safety and efficacy of DAV132 in association with antibiotics from the ß-lactam class,…

The event will bring together—digitally—hundreds of life science leaders for three days of productive cross-border partnering. We look forward to…

La biotech a mis au point un adsorbant intestinal qui capte les résidus d’antibiotiques évitant ainsi la sélection de bactéries…